The use of traditional plant medicines for non-insulin dependent diabetes mellitus in south Texas
The use of traditional plant medicines, as well as the factors associated with their use, were documented in 662 outpatients with non‐insulin dependent diabetes mellitus enrolled at six primary care clinics in South Texas. Forty‐nine percent of the patients reported using alternative treatments for...
Saved in:
Published in | Phytotherapy research Vol. 11; no. 7; pp. 512 - 517 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
Chichester, UK
John Wiley & Sons, Ltd
01.11.1997
Wiley |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The use of traditional plant medicines, as well as the factors associated with their use, were documented in 662 outpatients with non‐insulin dependent diabetes mellitus enrolled at six primary care clinics in South Texas. Forty‐nine percent of the patients reported using alternative treatments for their diabetes, which included 61 different traditional plant medicines. The four most commonly reported were nopal (Opuntia streptacantha) or the prickly pear cactus, chaya (Cnidoscolus chayamansa), míspero (Eriobotrya japonica) or loquat, and sávila (Aloe vera). Logistic regression was used to develop a multivariate model which indicated that alternative medicine use is positively associated with age and diabetes‐related ‘hassles’, and was more likely among border residents and individuals who were born in Mexico. Disease severity was not associated with the use of alternative treatments when controlling for other variables. Users of alternative treatments also appeared just as likely to adhere to orthodox biomedical treatment recommendations as non‐users. While preliminary reports in the literature suggest that some of the identified plants have hypoglycaemic properties, information is limited or nonexistent for many of the other plants. Given their preponderance in this region, some of these plants should be targeted for further investigation to document their efficacy or to screen for toxicity. © 1997 John Wiley & Sons, Ltd. |
---|---|
Bibliography: | Minority MEDTEP program of AHCPR - No. 3015941485 istex:D12A0298AEFAA7E10A22CDD09459D25BE68294D6 ark:/67375/WNG-F3GNRHHG-H ArticleID:PTR149 Texas Diabetes Council |
ISSN: | 0951-418X 1099-1573 |
DOI: | 10.1002/(SICI)1099-1573(199711)11:7<512::AID-PTR149>3.0.CO;2-H |